Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
M. Skrzypski, R. Dziadziuszko, A. Szymanowska, E. Jassem, P. Czapiewski, W. Biernat, W. Rzyman, R. Pawlowski, J. Jassem (Gdansk, Poland). The risk of distant metastases and prognosis prediction in early stage squamous cell lung cancer (SqCLC) by means of 3 microRNAs expression assessment. Eur Respir J 2011; 38: Suppl. 55, 1953

Member's Comments

No comment yet.

Related content which might interest you: Prognostic value of three-microRNA expression profile in early stage squamous cell lung cancer (SqCLC) Source: Annual Congress 2010 - New mechanisms and markers in human lung cancer Year: 2010 Analysis of risk factors for brain metastasis in locally advanced stage non-small cell carcinoma Source: Annual Congress 2010 - Best supportive care and palliation for lung cancer patients Year: 2010 Prognostic value of microRNAs profiling in early stage squamous cell lung cancer Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of lung cancer Year: 2009 Prevalence of silent brain metastasis (BM) in the initial staging of non-small cell lung carcinoma (NSCLC) Source: Annual Congress 2011 - Imaging, functional evaluation and staging for lung cancer patients Year: 2011 Prognostic factors in pathological stage IB nonsmall cell lung cancer greater than 3 cm Source: Eur Respir J 2010; 36: 1355-1361 Year: 2010 Pattern of relapse in stage I N0 non small cell lung cancer Source: Annual Congress 2009 - Preoperative functional assessment and surgery for malignant diseases Year: 2009 Staging with FDG-PET/CT influences stage-specific survival in non small cell lung cancer (NSCLC) Source: Annual Congress 2011 - Imaging in oncology and infectious diseases Year: 2011 Quality indicators in lung cancer care-review of resection rates in early stage NSCLC (non small cell lung cancer) at King’s Source: International Congress 2018 – Lung cancer: risk factors, supportive measures and quality improvement Year: 2018 TTF-1 for prediction of response to chemotherapy in patients with locally advanced or metastatic small cell lung cancer (SCLC) Source: Annual Congress 2012 - Treatment of lung cancer Year: 2012 Late lung metastasis of endometrial cancer. Two rare cases of patients with late lung metastasis of primary endometrial cancer 14 and 17 years after initial treatment Source: Annual Congress 2012 - Instructive clinical aspects of thoracic oncology Year: 2012 Age and stage at presentation in lung cancer Source: Annual Congress 2005 - Management of lung cancer: clinical problems Year: 2005 Preoperative biopsy risk for recurrence?: A retrospective study of risk factors for recurrence of stage 1A non-small cell lung cancer Source: International Congress 2017 – How to reach peripheral lesions: (radial EBUS, CLE, navigation, etc.) and treat airleaks Year: 2017 Validation of the prognostic value of growth pattern classification in operated non-small cell lung cancer (NSCLC) Source: Annual Congress 2010 - Actual challenges in thoracic surgery Year: 2010 Time lost for diagnostics of lung carcinoma related to disease stage and prognosis Source: Eur Respir J 2004; 24: Suppl. 48, 297s Year: 2004 Trail receptors as prognostic factors in non-small cell lung cancer Source: Annual Congress 2007 - Biology in thoracic oncology Year: 2007 Recruitment of podoplanin positive cancer-associated fibroblasts in metastatic lymph nodes predicts poor prognosis in pathological N2 stage III lung adenocarcinoma Source: Annual Congress 2012 - Prognosis of lung cancer Year: 2012 Predicting activity of EGFR (epidermal growth factor receptor) inhibitors in diffuse bronchiolo-alveolar carcinoma or so-called pneumonic adenocarcinoma Source: Annual Congress 2006 - Bronchiolo-alveolar carcinoma Year: 2006 Composite anatomical–clinical–molecular prognostic model in nonsmall cell lung cancer Source: Eur Respir J 2011; 37: 136-142 Year: 2011 Does expression of betatubulin 3 correlate between primary non small cells lung cancer tumor and metastases? Source: Annual Congress 2009 - Treatment of lung cancer Year: 2009 The prognostic impact of stage and performance status on surgically resected non-small cell lung cancer Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer Year: 2012